重大公告
Announcement on behalf of Obigen that the BOD resolved to issue 2023 employee stock options and the subscription rules.
1.Date of the board of directors resolution:2023/05/26 2.Issue period: Issued within two years since the date of approval of Board of Directors; issued at once …
Announcement on behalf of Obigen to change its financial and accounting officer
1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information …
The Company’s BOD resolved to amend the plan to disperse shareholding of Obigen (New Shareholding Dispersal Method)
1.Date of occurrence of the event:2023/05/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: …
The Company’s BOD resolved to amend the plan to disperse shareholding of AP Biosciences (New Shareholding Dispersal Method)
1.Date of occurrence of the event:2023/05/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: …
The Company’s Board of Directors resolved to issue 2023 employee stock options and the subscription rules.
1.Date of the board of directors resolution:2023/05/08 2.Issue period Pursuant to the “Regulations Governing the Offering and Issuance of Securities by Securities Issuers”, issued within …